Novavax shares are trading higher after the company announced
phase 1 data from its phase 1/2 trial was well-tolerated and had a
reassuring safety profile. JP Morgan also upgraded the company's
from Neutral to Overweight and raised its price target from $105 to
$275.
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
Novavax shares are trading higher
NVAX after hours 103 to 180 (wild)
Posted by morton7 on 5th of Aug 2020 at 08:16 am
Novavax shares are trading higher after the company announced phase 1 data from its phase 1/2 trial was well-tolerated and had a reassuring safety profile. JP Morgan also upgraded the company's from Neutral to Overweight and raised its price target from $105 to $275.